Trial Profile
Efficacy of OROS-methylphenidate on specific executive functioning deficits in adults with Attention deficit hyperactivity disorder (ADHD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Mar 2014
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 18 Jan 2014 Results published in the European Neuropsychopharmacology.
- 14 Aug 2013 New trial record